DEXECLEAR

Blemish Foaming Gel

New

DEXECLEAR 2 in 1 Blemish Foaming Gel cleanses acne-prone skin and reduces seborrhea and pimples.

Its formula, containing 2% salicylic acid, reduces excess sebum by 91% from the very first use*.

Legal information

*Clinical study on 33 subjects, 1 to 2 applications per day.

  • For whom?
    From age 15
  • Price
  • Texture
    Transparent gel

Patient relations

  • Application tips

    Apply 1 to 2 times a day to moistened skin. Rinse thoroughly.

Ingredients

Active ingredients:

Formula details:

WATER (AQUA)
SODIUM LAURETH SULFATE
COCAMIDE DEA
SALICYLIC ACID
COCAMIDOPROPYL BETAINE
CITRIC ACID
LENS ESCULENTA (LENTIL) SEED EXTRACT (LENS ESCULENTA SEED EXTRACT)
MENTHOL
MENTHYL LACTATE
PEG-40 HYDROGENATED CASTOR OIL
PENTYLENE GLYCOL
SODIUM BENZOATE
SODIUM HYDROXIDE
TOCOPHEROL
TRISODIUM ETHYLENEDIAMINE DISUCCINATE

Clinical results and publications

Efficacy results

-91 %

of sebum from the very first application*.

-18% OF NON-INFLAMMATORY LESIONS

adults and adolescents after 28 days lesions****.

 

****Clinical study on 43 adults and teenagers subjects

100%

Effectiveness observed by teenagers against pimples as early as 15 days of use, dermatologically confirmed **.

-64 %

of whiteheads after 1 month*** of use

Terms of use

*Clinical study on 33 subjects.
**Clinical study on 20 subjects.
***Clinical study on 33 subjects, 1 to 2 applications per day.

Discover the range

Filter by

All products
Hygiene
Sun Protection
md_dexeryl_dexeclear-mattifying-aquafluid_front_40ml_EN_3573994009023
DEXECLEAR
Mattifying Aquafluid SPF50+
View more
md_dexeryl_dexeclear-hydrating-soothing-cleanser_front_400ml_CEE1_3573994009139
DEXECLEAR
Hydrating Soothing Cleanser
View more

Contact us

Would you like to meet a sales representative?

Our medical sales representatives come to your workplace to answer all your questions about our brands and products.

Make an appointment

The product concerned may not be available in your country. Please contact your medical sales representative for further information.